Chronic Obstructive Pulmonary Disease Treatment Market revenue to cross USD 22 Billion by 2036, says Research Nester
February 29, 2024 07:30 ET
|
Research Nester
New York, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market size is estimated to attain at ~9% CAGR from 2024 to 2036. The market is expected...
Inhalation and Nasal Spray Market Worth USD 57.98 Billion in 2032 | Emergen Research
December 07, 2023 09:02 ET
|
Emergen Research
Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global Inhalation and Nasal Spray Market will be worth USD 57.98 billion by 2032, according to a current analysis by Emergen Research. An increasing...
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to reach USD 30.4 billion by 2031, expanding at a CAGR of 4.4%: TMR Report
August 09, 2023 05:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market is projected to flourish at a CAGR of 4.4% from 2022...
Genetic Chronic Obstructive Pulmonary Disease (COPD) Market to Surpass US$ 720.5 Million by 2030, Says Coherent Market Insights (CMI)
February 20, 2023 09:00 ET
|
CMI
Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global genetic chronic obstructive pulmonary disease (COPD) market is estimated to be valued at US$ 560.3...
Global Alpha-1 Antitrypsin Deficiency (A1ATD) Treatment Market to Reach US$ 10 Billion by 2033; Growing at an Impressive 12.8% CAGR – Future Market Insights, Inc.
January 09, 2023 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 09, 2023 (GLOBE NEWSWIRE) -- A recently published study by FMI expects the global Alpha-1 Antitrypsin Deficiency market to augment at a 12.8% CAGR from 2023 to 2033. By the end of...
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to Surpass US$ 21.8 Billion by 2026
May 28, 2019 08:30 ET
|
CMI
SEATTLE, May 28, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global chronic obstructive pulmonary disease (COPD) treatment market was valued at US$ 14,209.0 million in 2017 and...